Glenn Salkeld

7.2k total citations · 2 hit papers
127 papers, 5.5k citations indexed

About

Glenn Salkeld is a scholar working on General Health Professions, Economics and Econometrics and Oncology. According to data from OpenAlex, Glenn Salkeld has authored 127 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in General Health Professions, 47 papers in Economics and Econometrics and 30 papers in Oncology. Recurrent topics in Glenn Salkeld's work include Health Systems, Economic Evaluations, Quality of Life (40 papers), Patient-Provider Communication in Healthcare (22 papers) and Colorectal Cancer Screening and Detection (21 papers). Glenn Salkeld is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (40 papers), Patient-Provider Communication in Healthcare (22 papers) and Colorectal Cancer Screening and Detection (21 papers). Glenn Salkeld collaborates with scholars based in Australia, United Kingdom and United States. Glenn Salkeld's co-authors include Robert G. Cumming, Margaret H. Thomas, George Szonyi, Kirsten Howard, Michael J. Solomon, Phyllis Butow, Leonie Short, Les Irwig, Elizabeth O’Neill and Mandy Ryan and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Glenn Salkeld

123 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospective Study of the Impact of Fear of Falling on Activities of Daily Living, SF-36 Scores, and Nursing Home Admission

2000 701 citations Robert G. Cumming, Glenn Salkeld et al. profile →
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies

2014 339 citations Nicole Lowres, Lis Neubeck et al. Thrombosis and Haemostasis profile →

Peers

Countries citing papers authored by Glenn Salkeld

Since Specialization

Citations

This map shows the geographic impact of Glenn Salkeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Salkeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Salkeld more than expected).

Fields of papers citing papers by Glenn Salkeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Salkeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Salkeld. The network helps show where Glenn Salkeld may publish in the future.

Co-authorship network of co-authors of Glenn Salkeld

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Salkeld. A scholar is included among the top collaborators of Glenn Salkeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Salkeld. Glenn Salkeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A survey of Australian public attitudes towards funding of high cost cancer medicines 2020 ·Health Policy ·Narcyz Ghinea, Christine Critchley, (unknown), Ian Kerridge, Terence J. Campbell, Richard O. Day, Madlen Gazarian, David Isaacs, Winston Liauw, Ian Olver, (unknown), Sallie‐Anne Pearson, Glenn Salkeld, Wendy Lipworth	4
2	Qualitative Evaluation of Evidence‐Based Online Decision Aid and Resources for Osteoarthritis Management: Understanding Patient Perspectives 2018 ·Arthritis Care & Research ·Yun‐Hee Jeon, (unknown), (unknown), (unknown), (unknown), Glenn Salkeld, David J. Hunter	9
3	Community views on factors affecting medicines resource allocation: cross-sectional survey of 3080 adults in Australia 2018 ·Australian Health Review ·(unknown), Glenn Salkeld, Patrick J. Kelly, Wendy Lipworth, Dyfrig Hughes, Martin R. Stockler	9
4	Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia 2017 ·PLoS ONE ·(unknown), Glenn Salkeld, Patrick J. Kelly, Wendy Lipworth, Dyfrig Hughes, Martin R. Stockler	28
5	Towards Integrating the Principlist and Casuist Approaches to Ethical Decisions via Multi-Criterial Support 2016 ·Studies in health technology and informatics ·(unknown), Jesper Bo Nielsen, Glenn Salkeld, Jack Dowie	1
6	What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders 2015 ·BMJ Open ·(unknown), (unknown), (unknown), Glenn Salkeld, Magne Nylenna, Kari Nytrøen	51
7	Community screening for AF using iPhone ECG in pharmacies is feasible and cost effective for stroke prevention: the SEARCH-AF study. 2014 ·Thrombosis and Haemostasis ·Nicole Lowres, Lis Neubeck, Glenn Salkeld, Ines Krass, Andrew J. McLachlan, James Redfern, (unknown), (unknown), Adrian Bauman, (unknown), Christopher Wallenhorst, (unknown), David Brieger, Raymond W. Sy, Ben Freedman	3
8	Men's preferences and trade‐offs for prostate cancer screening: a discrete choice experiment 2014 ·Health Expectations ·Kirsten Howard, Glenn Salkeld, Manish I. Patel, Graham J. Mann, Michael Pignone	32
9	The Threat of Human Influenza: the Viruses, Disease Impacts, and Vaccine Solutions 2014 ·Infectious Disorders - Drug Targets ·J. Kevin Yin, Glenn Salkeld, Leon Heron, Gulam Khandaker, Harunor Rashid, Robert Booy	6
10	Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies breakdown → 2014 ·Thrombosis and Haemostasis ·Nicole Lowres, Lis Neubeck, Glenn Salkeld, Ines Krass, Andrew J. McLachlan, Julie Redfern, Alexandra Bennett, Tom Briffa, Adrian Bauman, Carlos Martínez, Christopher Wallenhorst, J. Lau, David Brieger, Raymond W. Sy, Ben Freedman	339
11	Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option 2012 ·BMC Gastroenterology ·Kathy Flitcroft, Les Irwig, Stacy M. Carter, Glenn Salkeld, James Gillespie	10
12	Getting evidence into policy: The need for deliberative strategies? 2011 ·Social Science & Medicine ·Kathy Flitcroft, James Gillespie, Glenn Salkeld, Stacy M. Carter, Lyndal Trevena	44
13	Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia? 2010 ·PharmacoEconomics ·(unknown), Patrick J. Kelly, Glenn Salkeld, Martin R. Stockler	47
14	HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility? 2007 ·Health Economics ·Kirsten Howard, Glenn Salkeld, Kirsten McCaffery, Les Irwig	20
15	Home bowel cancer tests and informed choice—is current information sufficient? 2003 ·Australian and New Zealand Journal of Public Health ·Kirsten Howard, Glenn Salkeld	7
16	Evidence‐based consumer choice: a case study in colorectal cancer screening 2003 ·Australian and New Zealand Journal of Public Health ·Glenn Salkeld, Michael J. Solomon, Leonie Short, Mandy Ryan, Jeanette Ward	48
17	A randomised trial of hip protector use by frail older women living in their own homes 2003 ·Injury Prevention ·Ian D. Cameron, Robert G. Cumming, Susan Kurrle, Susan Quine, Keri Lockwood, Glenn Salkeld, Terence Finnegan	70
18	Medical tests: women's reported and preferred decision‐making roles and preferences for information on benefits, side‐effects and false results 2002 ·Health Expectations ·Heather M. Davey, Alexandra Barratt, Elizabeth Davey, Phyllis Butow, Sally Redman, Nehmat Houssami, Glenn Salkeld	51
19	Health care expenditure and life expectancy in Australia - how well do we perform? 1996 ·Richard Taylor, Glenn Salkeld	1
20	Cost‐effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia 1996 ·Australian and New Zealand Journal of Public Health ·Glenn Salkeld, Graeme P. Young, Les Irwig, Marion Haas, Paul Glasziou	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact